Philip A. Sharp, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), bought 9,302 shares at $10.75 ($100K) on 2012-02-21, disclosed to the SEC on 2012-02-23.
Open-market purchase of $100k ALNY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ALNY | SELL | 2018-03-13 | $1.9M | — | Filing → |
| ALNY | SELL | 2017-02-03 | $2.0M | — | Filing → |
| ALNY | SELL | 2017-01-27 | $569K | — | Filing → |